India to Kenya: Ibrutinib Export Trade Route
India has recorded 21 verified shipments of Ibrutinib exported to Kenya, representing a combined trade value of $21.6K USD. This corridor is served by 8 active Indian exporters, with an average shipment value of $1.0K USD. The leading Indian exporter is R S SURGIPHARM PRIVATE LIMITED, which accounts for 30% of total export value with 4 shipments worth $6.5K USD. On the buying side, TO is the largest importer in Kenya with $12.5K USD in purchases. The top 3 suppliers — R S SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED, M T MADON EXPORTS — together control 83% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Kenya Ibrutinib corridor is one of India's established pharmaceutical export routes, with 21 shipments documented worth a combined $21.6K USD. The route is dominated by R S SURGIPHARM PRIVATE LIMITED, which alone accounts for roughly 30% of all export value, reflecting the consolidated nature of India's ibrutinib manufacturing sector.
Across 8 active suppliers, the average shipment value stands at $1.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with ibrutinib's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 25.6%, placing it at rank #20 among India's top ibrutinib export destinations globally.
On the import side, key buyers of Indian ibrutinib in Kenya include TO, CAWAKI AGENCIES, RAKAGIY GROUP LTD and 11 others. TO is the single largest importer with 6 shipments valued at $12.5K USD.
Route Characteristics
- Average transit15 days
- Peak seasonQ2
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#20
- Annual growth+25.6%
- Demand growth+23.4%
- Regulatory ease88/100
Top 10 Indian Ibrutinib Exporters to Kenya
Showing top 10 of 8 Indian suppliers exporting Ibrutinib to Kenya, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | R S SURGIPHARM PRIVATE LIMITED Avg $1.6K per shipment | 4 | $6.5K | 30.1% |
| 2 | R.S. SURGIPHARM PRIVATE LIMITED Avg $2.1K per shipment | 3 | $6.3K | 29.1% |
| 3 | M T MADON EXPORTS Avg $636 per shipment | 8 | $5.1K | 23.6% |
| 4 | MDS ENTERPRISES Avg $1.1K per shipment | 1 | $1.1K | 5.0% |
| 5 | R.S. SURGIPHARM PRIVATE LIMITED Avg $961 per shipment | 1 | $961 | 4.5% |
| 6 | PLASMA LIFE CARE Avg $367 per shipment | 2 | $734 | 3.4% |
| 7 | ASPIRA BIOHEALTH LLP Avg $699 per shipment | 1 | $699 | 3.2% |
| 8 | 3S CORPORATION Avg $245 per shipment | 1 | $245 | 1.1% |
This table shows the top 10 of 8 Indian companies exporting ibrutinib to Kenya, ranked by total trade value. The listed exporters are: R S SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED, M T MADON EXPORTS, MDS ENTERPRISES, R.S. SURGIPHARM PRIVATE LIMITED , PLASMA LIFE CARE, ASPIRA BIOHEALTH LLP, 3S CORPORATION. R S SURGIPHARM PRIVATE LIMITED is the dominant supplier with 4 shipments worth $6.5K USD, giving it a 30% market share. The top 3 suppliers together account for 83% of the total trade value on this route.
Top 10 Ibrutinib Importers in Kenya
Showing top 10 of 14 known buyers in Kenya receiving Ibrutinib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian ibrutinib in Kenya include TO, CAWAKI AGENCIES, RAKAGIY GROUP LTD, TO THE BUYER OF TO THE MANAGER, TO , among 14 total buyers. The largest importer is TO, accounting for $12.5K USD across 6 shipments — representing 58% of all ibrutinib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TO | 6 | $12.5K | 57.7% |
| 2 | CAWAKI AGENCIES | 1 | $1.7K | 7.8% |
| 3 | RAKAGIY GROUP LTD | 1 | $1.5K | 7.1% |
| 4 | TO THE BUYER OF TO THE MANAGER | 1 | $1.1K | 5.0% |
| 5 | TO | 1 | $961 | 4.5% |
| 6 | RANGECHEM PHARMACEUTICALS LIMITED | 3 | $854 | 4.0% |
| 7 | TO THE ORDER OF INVOICE RAISED TO | 1 | $699 | 3.2% |
| 8 | ABC PHARMACY LTD | 1 | $525 | 2.4% |
| 9 | MEDSERV AFRICA LIMITED | 1 | $407 | 1.9% |
| 10 | MEDSERV AFRICA LTD | 1 | $327 | 1.5% |
Showing top 10 of 14 Ibrutinib importers in Kenya on this route.
Top 10 Ibrutinib Formulations Imported by Kenya
Showing top 10 of 20 product formulations shipped on the India to Kenya Ibrutinib route, ranked by trade value
Kenya imports a wide range of ibrutinib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — (HARMLESS MEDICINES FOR INJECTABLEAND CAPSULES AND TABLETS) IBRUTINIB CAPSULES 140MG (UNIT PACK : 1X30) — accounts for $4.6K USD across 1 shipments. There are 20 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | (HARMLESS MEDICINES FOR INJECTABLEAND CAPSULES AND TABLETS) IBRUTINIB CAPSULES 140MG (UNIT PACK : 1X30) | 1 | $4.6K | 21.3% |
| 2 | HARMLESS MEDICINES FOR INJECTABLEAND CAPSULES AND TABLETS Ibrutinib Capsules 140mg 1x30 | 1 | $4.4K | 20.5% |
| 3 | IBRUTINIB 140MG CAP 1X30 | 2 | $1.8K | 8.1% |
| 4 | IBRUMED 140MG CAPSULE [44 BTL X 30 = 1320 CAP] EACH TAB. CONT.IBRUTINIB 140MG | 1 | $1.7K | 7.8% |
| 5 | NITIB 140MG CAPSULE[30NOS X 30 = 900 TAB]EACH TAB CONT IBRUTINIB 140MG | 1 | $1.5K | 7.1% |
| 6 | IBRUTINIB 140 NITIB 140 | 1 | $1.1K | 5.0% |
| 7 | (HARMLESS MEDICINES FOR INJECTABLEAND CAPSULES AND TABLETS)Ibrutinib Capsules 140mg(1x30) | 1 | $1.1K | 5.0% |
| 8 | IBRUTINIB 140MG CAP (1X30) | 1 | $961 | 4.5% |
| 9 | IBRUTINIBCAPSULES140MGBRAND:IBRUNAT140CAPSULESBATCH:502356MFGDT:SEP-23EXPDT:AUG-26 | 1 | $699 | 3.2% |
| 10 | (HARMLESS MEDICINES INJECATABLE AND TABLETS) IBRUTINIB 140MG CAPSULES1X30NOS | 1 | $608 | 2.8% |
Showing top 10 of 20 Ibrutinib formulations imported by Kenya on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 8 shipments. Transit time averages 15 days by sea.
Market Dynamics
India's ibrutinib exports to Kenya are driven primarily by a handful of large-scale manufacturers. R S SURGIPHARM PRIVATE LIMITED with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 8 active exporters signals a competitive but concentrated market — buyers in Kenya benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — R S SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED, M T MADON EXPORTS — together account for 83% of total trade value on this route. The average shipment value of $1.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicines for injectableand capsules and tablets ibrutinib capsules 140mg 1x30 and ibrutinib 140mg cap 1x30, suggesting that buyers in Kenya tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, TO is the largest importer with 6 shipments worth $12.5K USD — representing 58% of all ibrutinib imports from India on this route. A total of 14 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $21.6K
- Avg. Shipment
- $1.0K
- Suppliers
- 8
- Buyers
- 14
- Transit (Sea)
- ~15 days
- Annual Growth
- +25.6%
Other Ibrutinib Routes
Unlock the Full India to Kenya Ibrutinib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 21 shipments on this route.
Frequently Asked Questions — India to Kenya Ibrutinib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Ibrutinib to Kenya?
The leading Indian exporters of Ibrutinib to Kenya are R S SURGIPHARM PRIVATE LIMITED, R.S. SURGIPHARM PRIVATE LIMITED, M T MADON EXPORTS. R S SURGIPHARM PRIVATE LIMITED holds the largest market share at approximately 30% of total trade value on this route.
Q What is the total value of Ibrutinib exports from India to Kenya?
India exports Ibrutinib to Kenya worth approximately $21.6K USD across 21 recorded shipments. The average value per shipment is $1.0K USD.
Q Which ports does India use to ship Ibrutinib to Kenya?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 8 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to Kenya for Ibrutinib?
The average transit time for Ibrutinib shipments from India to Kenya is approximately 15 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Kenya Ibrutinib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.6% with demand growth tracking at 23.4%. The route is ranked #20 among India's top Ibrutinib export destinations globally.
Q How many suppliers are active on the India to Kenya Ibrutinib route?
There are currently 8 active Indian suppliers exporting Ibrutinib to Kenya. The market is moderately concentrated with R S SURGIPHARM PRIVATE LIMITED accounting for 30% of total shipment value.
Q Who are the main importers of Ibrutinib from India in Kenya?
The leading importers of Indian Ibrutinib in Kenya include TO, CAWAKI AGENCIES, RAKAGIY GROUP LTD, TO THE BUYER OF TO THE MANAGER, TO . TO is the largest buyer with 6 shipments worth $12.5K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Kenya export trade corridor identified from Indian Customs (DGFT) records for Ibrutinib.
- 2.Supplier/Buyer Matching: 8 Indian exporters and 14 importers in Kenya matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 21 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
21 Verified Shipments
8 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists